Search

Neeraj Sharma

Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )

Most Active Art Unit
2659
Art Unit(s)
2659, 2626
Total Applications
582
Issued Applications
475
Pending Applications
51
Abandoned Applications
71

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7651280 [patent_doc_number] => 20110300549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Treatment of Development-Related Disorders' [patent_app_type] => utility [patent_app_number] => 13/206003 [patent_app_country] => US [patent_app_date] => 2011-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18821 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300549.pdf [firstpage_image] =>[orig_patent_app_number] => 13206003 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/206003
Treatment of Development-Related Disorders Aug 8, 2011 Abandoned
Array ( [id] => 11343504 [patent_doc_number] => 09527899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-27 [patent_title] => 'Recombinant human follicle-stimulating hormone' [patent_app_type] => utility [patent_app_number] => 13/814059 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15492 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814059 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/814059
Recombinant human follicle-stimulating hormone Aug 3, 2011 Issued
Array ( [id] => 9016315 [patent_doc_number] => 20130231279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'OXYTOCIN TREATMENT TO IMPROVE MEMORY AND MODIFY BLOOD GLUCOSE' [patent_app_type] => utility [patent_app_number] => 13/812850 [patent_app_country] => US [patent_app_date] => 2011-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12530 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812850 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/812850
Intranasal oxytocin treatment to improve schizophrenia Jul 29, 2011 Issued
Array ( [id] => 7767855 [patent_doc_number] => 20120035109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'FOLLICLE STIMULATING HORMONE SUPERAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/187956 [patent_app_country] => US [patent_app_date] => 2011-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 16628 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035109.pdf [firstpage_image] =>[orig_patent_app_number] => 13187956 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/187956
Follicle stimulating hormone superagonists Jul 20, 2011 Issued
Array ( [id] => 7710111 [patent_doc_number] => 20120003180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'PERLECAN DOMAIN V PROTECTS, REPAIRS AND RESTORES ISCHEMIC BRAIN STROKE INJURY AND MOTOR FUNCTION' [patent_app_type] => utility [patent_app_number] => 13/175518 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 33900 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13175518 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/175518
Perlecan domain V protects, repairs and restores ischemic brain stroke injury and motor function Jun 30, 2011 Issued
Array ( [id] => 9843913 [patent_doc_number] => 08945828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Method of identifying fetal antigens or cell surface markers using phage display technology' [patent_app_type] => utility [patent_app_number] => 13/169922 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20815 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169922 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/169922
Method of identifying fetal antigens or cell surface markers using phage display technology Jun 26, 2011 Issued
Array ( [id] => 7509859 [patent_doc_number] => 20110256097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle' [patent_app_type] => utility [patent_app_number] => 13/169897 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31685 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256097.pdf [firstpage_image] =>[orig_patent_app_number] => 13169897 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/169897
Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle Jun 26, 2011 Abandoned
Array ( [id] => 9041205 [patent_doc_number] => 20130243843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'Vitronectin:Keratinocyte Growth Factor Chimeras' [patent_app_type] => utility [patent_app_number] => 13/701472 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9867 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701472 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/701472
Vitronectin:keratinocyte growth factor chimeras Jun 2, 2011 Issued
Array ( [id] => 7744258 [patent_doc_number] => 20120021984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Glycoprotein Hormone Analogs' [patent_app_type] => utility [patent_app_number] => 13/114861 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 26577 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021984.pdf [firstpage_image] =>[orig_patent_app_number] => 13114861 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/114861
Salmon follitropin hormone analogs May 23, 2011 Issued
Array ( [id] => 7499261 [patent_doc_number] => 20110262390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/113552 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25946 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262390.pdf [firstpage_image] =>[orig_patent_app_number] => 13113552 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/113552
COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISORDERS May 22, 2011 Abandoned
Array ( [id] => 8815132 [patent_doc_number] => 20130116177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'USE OF AROMATASE INHIBITORS FOR SYNCHRONIZING OVULATION, INDUCING SUPEROVULATION OR DOUBLE OVULATION AND IMPROVING TWINNING AND FERTILITY IN A MAMMAL' [patent_app_type] => utility [patent_app_number] => 13/698402 [patent_app_country] => US [patent_app_date] => 2011-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18484 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698402 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/698402
Methods of administering an aromatase inhibitor, prostaglandin and GnRH for regulating ovulation in cattle May 18, 2011 Issued
Array ( [id] => 6090353 [patent_doc_number] => 20110218147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'ACTIVIN-ACTRIIA ANTAGONISTS FOR INHIBITING GERM CELL MATURATION' [patent_app_type] => utility [patent_app_number] => 13/111393 [patent_app_country] => US [patent_app_date] => 2011-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 23004 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218147.pdf [firstpage_image] =>[orig_patent_app_number] => 13111393 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/111393
Activin-actriia antagonists for inhibiting germ cell maturation May 18, 2011 Issued
Array ( [id] => 8928414 [patent_doc_number] => 20130184174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'DETECTION METHOD FOR 305 FERTILITY-ASSOCIATED SPERM LOCALIZATION PROTEINS EX-PRESSED IN HUMAN TESTIS AND EPIDIDYMIS' [patent_app_type] => utility [patent_app_number] => 13/700218 [patent_app_country] => US [patent_app_date] => 2011-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10099 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700218 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/700218
Detection method for 305 fertility-associated sperm localization proteins expressed in human testis and epididymis May 17, 2011 Issued
Array ( [id] => 8062889 [patent_doc_number] => 20110245592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Secretome Profile-Facilitated In Vitro Fertilization' [patent_app_type] => utility [patent_app_number] => 13/081463 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9392 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245592.pdf [firstpage_image] =>[orig_patent_app_number] => 13081463 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/081463
Secretome Profile-Facilitated In Vitro Fertilization Apr 5, 2011 Abandoned
Array ( [id] => 6177399 [patent_doc_number] => 20110178012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'USE OF HUMAN CHORIONIC GONADOTROPIN ORALLY FOR THE TREATMENT OF OVERWEIGHT (OBESITY) ASSOCIATED WITH HIGH BLOOD TENSION, NON-INSULIN-DEPENDANT DIABETES, HYPERCHOLESTEROLEMIA, DYSLIPIDEMIAS AND LIPODYSTROPHY.' [patent_app_type] => utility [patent_app_number] => 13/078474 [patent_app_country] => US [patent_app_date] => 2011-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 460 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178012.pdf [firstpage_image] =>[orig_patent_app_number] => 13078474 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/078474
USE OF HUMAN CHORIONIC GONADOTROPIN ORALLY FOR THE TREATMENT OF OVERWEIGHT (OBESITY) ASSOCIATED WITH HIGH BLOOD TENSION, NON-INSULIN-DEPENDANT DIABETES, HYPERCHOLESTEROLEMIA, DYSLIPIDEMIAS AND LIPODYSTROPHY. Mar 31, 2011 Abandoned
Array ( [id] => 7587242 [patent_doc_number] => 20110281752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'BETA-SECRETASE ENZYME COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/070413 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 31378 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281752.pdf [firstpage_image] =>[orig_patent_app_number] => 13070413 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/070413
BETA-SECRETASE ENZYME COMPOSITIONS AND METHODS Mar 22, 2011 Abandoned
Array ( [id] => 7490155 [patent_doc_number] => 20110237523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'CONTRACEPTIVE PEPTIDES DERIVED FROM THE VENOM OF THE SPIDER Latrodectus mirabilis, NUCLEOTIDE SEQUENCES TO TRANSFORM A MICROORGANISM TO PRODUCE SAID PEPTIDES; METHODS TO OBTAIN THE PEPTIDES; PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/053751 [patent_app_country] => US [patent_app_date] => 2011-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4227 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237523.pdf [firstpage_image] =>[orig_patent_app_number] => 13053751 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/053751
Contraceptive peptides derived from the venom of the spider Latrodectus mirabilis, nucleotide sequences to transform a microorganism to produce said peptides; methods to obtain the peptides; pharmaceutical compositions containing thereof and use thereof Mar 21, 2011 Issued
Array ( [id] => 8417603 [patent_doc_number] => 20120245104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'NOVEL RETRO-INVERSO LEPTIN PEPTIDE ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/053636 [patent_app_country] => US [patent_app_date] => 2011-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14901 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13053636 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/053636
NOVEL RETRO-INVERSO LEPTIN PEPTIDE ANTAGONISTS Mar 21, 2011 Abandoned
Array ( [id] => 9026542 [patent_doc_number] => 08536124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Artificial decapeptide for inducing vitellogenesis in fish' [patent_app_type] => utility [patent_app_number] => 13/050485 [patent_app_country] => US [patent_app_date] => 2011-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2677 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13050485 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/050485
Artificial decapeptide for inducing vitellogenesis in fish Mar 16, 2011 Issued
Array ( [id] => 8566128 [patent_doc_number] => 20120328699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'METHOD AND COMPOSITION FOR TREATMENT OF SKELETAL DYSPLASIAS' [patent_app_type] => utility [patent_app_number] => 13/006129 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11001 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13006129 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/006129
METHOD AND COMPOSITION FOR TREATMENT OF SKELETAL DYSPLASIAS Jan 12, 2011 Abandoned
Menu